6′-((6-aminopyrimidin-4-yl)amino)-8′-methyl-2’H-spiro[cyclohexane-1,3′-imidazo[1,5a]pyridine]-1′,5′-dione hydrochloride

6′-((6-aminopyrimidin-4-yl)amino)-8′-methyl-2’H-spiro[cyclohexane-1,3′-imidazo[1,5a]pyridine]-1′,5′-dione hydrochloride
Trade Name
Orphan Indication Diffuse Large B-cell Lymphoma
USA Market Approval USA
USA Designation Date 2017-02-23 00:00:00
Sponsor eFFECTOR Therapeutics;11180 Roselle Street, Suite A;San Diego, California, 92121